Showing results (561-570 of 569) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 569 results.
Gut|September 14, 2010
High detection rate of adenomas in familial colorectal cancerA E van der Meulen-de Jong, H Morreau, M C J M Becx, et al.
American Journal of Human Genetics|January 20, 2023
Web-accessible application for identifying pathogenic transcripts with RNA-seq: Increased sensitivity in diagnosis of neurodevelopmental disordersJordy Dekker, Rachel Schot, Michiel Bongaerts, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 2026
Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer - PORTEC-4a an international, randomised, phase 3 trialAnne Sophie V M van den Heerik, Nanda Horeweg, Marie A D Haverkort, et al.
Gastroenterology|March 9, 2010
One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndromeHans F A Vasen, Mohamed Abdirahman, Richard Brohet, et al.
The Lancet. Oncology|December 25, 2025
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trialAnne Sophie V M van den Heerik, Nanda Horeweg, Marie A D Haverkort, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2020
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancerAnne Sophie V M van den Heerik, Nanda Horeweg, Remi A Nout, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Randomized Comparison of Surveillance Intervals in Familial Colorectal CancerSimone D Hennink, Andrea E van der Meulen-de Jong, Ron Wolterbeek, et al.
Trials|February 21, 2023
LOFIT (Lifestyle front Office For Integrating lifestyle medicine in the Treatment of patients): a novel care model towards community-based options for lifestyle change-study protocolMarlinde L van Dijk, Leonie M Te Loo, Joyce Vrijsen, et al.
HGG Advances|September 24, 2025
Routine RNA-based analysis of potential splicing variants facilitates genomic diagnostics and reveals limitations of in silico prediction toolsMark Drost, Jordy Dekker, Federico Ferraro, et al.
Pageof 57